Clinical characteristics of patients enrolled (n = 17)
| . | No . | |
|---|---|---|
| Primary diagnosis | ||
| Metastatic prostate adenocarcinoma | 11 | |
| Metastatic ovarian carcinoma | 2 | |
| Metastatic breast carcinoma | 3 | |
| Metastatic carcinoma of the fallopian tube | 1 | |
| Gender | ||
| Males | 11 | |
| Females | 6 | |
| Median age in y (range) | 65 (42-76) | |
| Race | ||
| White | 14 | |
| Hispanic | 2 | |
| Asian | 1 | |
| ECOG performance status (median) | ||
| 0 | 2 | |
| 1 | 10 | |
| 2 | 5 | |
| Response | ||
| Partial response | 1 | |
| Progressive disease | 6 | |
| Stable disease | 5 | |
| Withdrawal before response assessment | 3 | |
| Death on study | 2 | |
| . | No . | |
|---|---|---|
| Primary diagnosis | ||
| Metastatic prostate adenocarcinoma | 11 | |
| Metastatic ovarian carcinoma | 2 | |
| Metastatic breast carcinoma | 3 | |
| Metastatic carcinoma of the fallopian tube | 1 | |
| Gender | ||
| Males | 11 | |
| Females | 6 | |
| Median age in y (range) | 65 (42-76) | |
| Race | ||
| White | 14 | |
| Hispanic | 2 | |
| Asian | 1 | |
| ECOG performance status (median) | ||
| 0 | 2 | |
| 1 | 10 | |
| 2 | 5 | |
| Response | ||
| Partial response | 1 | |
| Progressive disease | 6 | |
| Stable disease | 5 | |
| Withdrawal before response assessment | 3 | |
| Death on study | 2 | |
Abbreviation: ECOG, Eastern Cooperative Oncology Group.